| Product Code: ETC13150460 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Next Generation Cancer Diagnostics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Next Generation Cancer Diagnostics Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Next Generation Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 North America Next Generation Cancer Diagnostics Market - Industry Life Cycle |
3.4 North America Next Generation Cancer Diagnostics Market - Porter's Five Forces |
3.5 North America Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 North America Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 North America Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Cancer, 2021 & 2031F |
3.9 North America Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Function, 2021 & 2031F |
4 North America Next Generation Cancer Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Next Generation Cancer Diagnostics Market Trends |
6 North America Next Generation Cancer Diagnostics Market, 2021 - 2031 |
6.1 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Next-generation Sequencing, 2021 - 2031 |
6.1.3 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By qPCR & Multiplexing, 2021 - 2031 |
6.1.4 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), 2021 - 2031 |
6.1.5 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Protein Microarrays, 2021 - 2031 |
6.1.6 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By DNA Microarrays, 2021 - 2031 |
6.2 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Biomarker Development, 2021 - 2031 |
6.2.3 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By CTC Analysis, 2021 - 2031 |
6.2.4 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Proteomic Analysis, 2021 - 2031 |
6.2.5 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Epigenetic Analysis, 2021 - 2031 |
6.2.6 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Genetic Analysis, 2021 - 2031 |
6.3 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Cancer, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Lung Cancer, 2021 - 2031 |
6.3.3 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Breast Cancer, 2021 - 2031 |
6.3.4 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Colorectal Cancer, 2021 - 2031 |
6.3.5 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Cervical Cancer, 2021 - 2031 |
6.3.6 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Function, 2021 - 2031 |
6.4.2 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Therapeutic Monitoring, 2021 - 2031 |
6.4.3 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Companion Diagnostics, 2021 - 2031 |
6.4.4 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Prognostics, 2021 - 2031 |
6.4.5 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Cancer Screening, 2021 - 2031 |
6.4.6 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Risk Analysis, 2021 - 2031 |
7 North America Next Generation Cancer Diagnostics Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.1 United States (US) Next Generation Cancer Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.2 Canada Next Generation Cancer Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.3 Rest of North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3 North America Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
7.3.1 United States (US) Next Generation Cancer Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.2 Canada Next Generation Cancer Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.3 Rest of North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Cancer, 2021 - 2031 |
7.4.1 United States (US) Next Generation Cancer Diagnostics Market, Revenues & Volume, By Cancer, 2021 - 2031 |
7.4.2 Canada Next Generation Cancer Diagnostics Market, Revenues & Volume, By Cancer, 2021 - 2031 |
7.4.3 Rest of North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Cancer, 2021 - 2031 |
7.5 North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Function, 2021 - 2031 |
7.5.1 United States (US) Next Generation Cancer Diagnostics Market, Revenues & Volume, By Function, 2021 - 2031 |
7.5.2 Canada Next Generation Cancer Diagnostics Market, Revenues & Volume, By Function, 2021 - 2031 |
7.5.3 Rest of North America Next Generation Cancer Diagnostics Market, Revenues & Volume, By Function, 2021 - 2031 |
8 North America Next Generation Cancer Diagnostics Market Key Performance Indicators |
9 North America Next Generation Cancer Diagnostics Market - Export/Import By Countries Assessment |
10 North America Next Generation Cancer Diagnostics Market - Opportunity Assessment |
10.1 North America Next Generation Cancer Diagnostics Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Next Generation Cancer Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.3 North America Next Generation Cancer Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
10.4 North America Next Generation Cancer Diagnostics Market Opportunity Assessment, By Cancer, 2021 & 2031F |
10.5 North America Next Generation Cancer Diagnostics Market Opportunity Assessment, By Function, 2021 & 2031F |
11 North America Next Generation Cancer Diagnostics Market - Competitive Landscape |
11.1 North America Next Generation Cancer Diagnostics Market Revenue Share, By Companies, 2022 |
11.2 North America Next Generation Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here